INTRODUCTION
============

Recently, although advanced trauma care such as damage control surgery and resuscitation have been developed, uncontrolled bleeding remains the most common cause of preventable death among severe trauma patients.[@B1][@B2] The core concept of damage control resuscitation (DCR) consists of a 1:1:1 blood component transfusion ratio as well as early recognition of hemorrhage with early hemostasis.[@B2] However, even a well-experienced trauma surgeon\'s gestalt is not enough to recognize any underlying severe hemorrhage.[@B3] Thus, early recognition of the need for transfusion in severe traumatic patients has been a challenge for trauma surgeons, and it is a crucial sign that implies a major catastrophe.

The traditional definition of massive transfusion (MT) is a patient who receives 10 or more units of packed red blood cells (PRBC) within the first 24 hours.[@B4] However, the conventional definition of MT is an arbitrary and insufficient measurement for predicting mortality with substantial survival bias.[@B4] Many patients die within 24 hours, and they are excluded by the traditional MT definition. Therefore, survival bias can arise in these cases, and the estimated risk can be biased (usually underestimated).[@B5] In addition, it is necessary to assess the risk for mortality within first 24 hours. As a result, some investigators argued that a modified definition of MT should be as follows: patients receiving 5 or more units of PRBC in 4 hours[@B6] and 10 or more units of PRBC in 6 hours.[@B7] Instead, Savage et al.[@B8] proposed an alternative definition of significant blood transfusion requirement. It focused on the concept of critical administration threshold (CAT), which is defined as any patients receiving 3 or more units of PRBC within the first hour. Another alternative metric, which was introduced by Rahbar et al.,[@B9] is the resuscitation intensity (RI), defined as the sum of each unit of resuscitation product, including each unit of blood product (PRBC, plasma, or platelets), every 500 mL of colloid solution, and every 1,000 mL of crystalloid solution administrated within the first 30 minutes. Previous studies demonstrated that both CAT and RI performed better than MT in terms of predicting risks for early mortality.[@B10]

The aim of this study was to assess the value of MT, CAT, and RI as predictors of the mortality of trauma patients with severe hemorrhage. In a meta-analysis, the estimated mortality rates of trauma patients and injury severity scores (ISS) were analyzed through division into evaluating predictors. In addition, diagnostic test accuracy (DTA) reviews were conducted to compare the prognostic values of various predictors.

METHODS
=======

Published study search and selection criteria
---------------------------------------------

This study was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) statement.[@B11] Relevant articles were obtained by searching the PubMed databases through February 15, 2019. This database was searched using the following keywords: "(trauma) AND (hemorrhage) AND (transfusion) AND (mortality)" and "(trauma) AND (critical administration threshold) AND (transfusion) AND (mortality)." In addition, we searched the reference lists of relevant articles manually. The titles and abstracts of all searched articles were screened for exclusion. Review articles and previous meta-analyses were also screened to obtain additional eligible studies. Search results were then reviewed, and articles were included if the study investigated the trauma patients and provided information on the mortality of patients with MT. Those articles that were case reports, non-original articles, or non-English language publications were excluded.

Data extraction
---------------

Data from all eligible studies were extracted by two individual authors. Extracted data from each of the eligible studies included the following[@B3][@B6][@B9][@B10][@B12][@B13][@B14][@B15][@B16][@B17][@B18][@B19][@B20][@B21][@B22][@B23][@B24]: first author\'s name; year of publication; study location; study design; study period; number of patients analyzed; and patients\' ages, ISS, and mortality with and without MT. In addition, the number of true positives, false positives, false negatives, and true negatives for each MT (≥ 10 pRBC/24 hours), CAT (≥ 3 pRBC/1 hour), and RI (≥ 4 units) were investigated to obtain the sensitivity, specificity, diagnostic odds ratio (OR), and summary receiver operating characteristic (SROC) curve.

Quality assessment
------------------

All studies were independently reviewed by two investigators. Any disagreement concerning the study selection and data extraction were resolved by consensus. As recommended by the Cochrane Collaboration, Prediction model Risk Of Bias ASsessment Tool (PROBAST) was used to assess the risk of bias and applicability of diagnostic and prognostic prediction model studies.[@B25] The disagreement was resolved by discussion with the participation of the third independent author.

Statistical analysis
--------------------

To obtain the estimated mortality rates of traumatic patients with MT, a meta-analysis was performed using the Comprehensive Meta-Analysis software package (Biostat, Englewood, NJ, USA). The mortality was investigated from eligible studies. Because the eligible studies used populations with various traumas, a random-effects model was more appropriate than a fixed-effects model. Heterogeneity between the eligible studies was checked using probability statistics (*P* value). To evaluate publication bias, Begg\'s funnel plot and Egger\'s test were conducted. The results with *P* \< 0.05 were considered statistically significant. If significant publication bias was found, the fail-safe N and trim-fill tests were also conducted to confirm the degree of publication bias. The results were considered statistically significant with *P* \< 0.05.

Additionally, we performed DTA reviews of MT, CAT, and RI for predicting mortality using the Meta-DiSc program (version 1.4; Biostatistics, the Ramon y Cajal Hospital, Madrid, Spain). We calculated the pooled sensitivity, specificity, and diagnostic ORs according to individual data collected from each eligible study in the various categories of comparison. By plotting the "sensitivity" and "1−specificity" of each study, the SROC curve was constructed first, and the curve fitting was performed through linear regression using the Moses-Littenberg linear model. Because each of the data was heterogeneous, the accuracy data were pooled by fitting the SROC curve and measuring the value of the area under the curve (AUC). An AUC close to 1 means the test is strong, and an AUC close to 0.5 means the test is considered poor. A subgroup analysis based on evaluation time and evaluation tool was conducted.

RESULTS
=======

Selection and characteristics
-----------------------------

A total of 1,262 studies were searched and identified through database searching. Among the searched studies, 823 were excluded due to insufficient information. An additional 263 studies were excluded because they were non-original, 81 were excluded owing to being a study for other diseases, 10 were excluded because they were studies about non-humans, and 6 studies were excluded because they were written in a non-English language. Finally, 17 studies comprising 17,511 patients were included in the present meta-analysis and DTA review ([Fig. 1](#F1){ref-type="fig"} and [Table 1](#T1){ref-type="table"}), and detailed information about the eligible studies is shown in [Table 1](#T1){ref-type="table"}.

![Flow diagram for identification of eligible studies.](jkms-34-e318-g001){#F1}

###### Main characteristics of the eligible studies

![](jkms-34-e318-i001)

  Study                          Location                 Study design                              Study period   Assessment   Subgroup                No. of patients   Age, yr   ISS           
  ------------------------------ ------------------------ ----------------------------------------- -------------- ------------ ----------------------- ----------------- --------- ------ ------ ------
  Boutefnouchet et al.[@B12]     UK                       Observational, single center              2008--2010     MT           MTP 1                   52                40.8      16.4   25.5   13.0
  MTP 2                          66                       41.3                                      19.8           30.7         14.2                                                              
  Broxton et al.[@B13]           USA                      Observational, single center              2014--2015     MT           MT (+)                  16                42.0      17.0          
  MT (−)                         42                       44.0                                      21.0                                                                                          
  Hamidi et al.[@B14]            USA                      Observational, TQIP database              2013--2014     MT           Level I trauma center   2,184             40.0      20.0   29.5   3.7
  MT                             Level II trauma center   594                                       41.0           19.0         27.5                    3.3                                       
  Huber-Wagner et al.[@B15]      Germany                  Observational, German database^a^         1993--2001     MT           Group I (0--9 pRBC)     7,021                                     
  Group II (10--19 pRBC)         661                                                                                                                                                              
  Group III (20--29 pRBC)        253                                                                                                                                                              
  Group IV (≥ 30 pRBC)           148                                                                                                                                                              
  Johansson et al.[@B16]         Denmark                  Observational, single center              2010--2011     MT           Non-survivors           21                63.4      8.5    32.2   3.3
  Survivors                      161                      40.8                                      4.2            15.3         2.8                                                               
  Maegele et al.[@B17]           Germany                  Observational, German database^a^         2002--2006     MT           pRBC:FFP ratio \> 1.1   484               41.0      19.0   41.0   16.0
  pRBC:FFP ratio 0.9--1.1        114                      40.0                                      18.0           41.0         14.0                                                              
  pRBC:FFP ratio \< 0.9          115                      37.0                                      16.0           41.0         13.0                                                              
  Meyer et al.[@B10]             USA                      RCT                                       2012--2013     MT           With MT                 301               35.3      4.5    32.5   3.3
  PROPPR (secondary analysis)    CAT                      With CAT                                  521            35.3         4.2                     28.3              3.8                     
  RI                             ≥ 4 units                445                                       35.8           4.5          29.3                    3.8                                       
  Moore et al.[@B18]             USA                      Observational, multicenter (7 centers)    2005--2006     MT           With MT                 113               38.0      17.0   32.0   16.0
  Without MT                     267                      39.0                                      17.0           26.0         15.0                                                              
  Murry et al.[@B19]             USA                      Observational, single center              2011--2013     MT           Non-elderly (\< 60)     52                35.0      11.0   32.0   15.8
  Elderly (≥ 60)                 14                       73.0                                      12.0           28.0         10.7                                                              
  Nunez et al.[@B20]             USA                      Observational, single center              2005--2006     MT           With MT                 76                40.0      18.0   32.7   3.2
  Without MT                     510                      48.0                                      24.0           22.0         4.0                                                               
  Ogura et al.[@B21]             Japan                    Observational, single center              2008--2009     MT           With MT                 62                64.0      20.7   30.1   14.4
  2010--2012                     Without MT               57                                        50.6           26.6         26.1                    76.5                                      
  Ohmori et al.[@B22]            Japan                    Observational, single center              2007--2015     MT           With MT                 74                78.0      1.7    34.0   2.8
  Without MT                     306                      77.0                                      1.8            22.0         1.7                                                               
  Mitra et al.[@B6]              Australia                Observational, single center              2004--2008                  With MT                 303               42.8      19.9   34.8   3.2
  Without MT                     84                       43.0                                      19.2           29.3         3.8                                                               
  Pommerening et al.[@B3]        USA                      Observational, multicenter (10 centers)   2009--2010     MT           With MT                 221               38.0      4.7           
  Without MT                     745                      38.5                                      5.0                                                                                           
  Rahbar et al.[@B9]             USA                      Observational, multicenter (10 centers)   2009--2010     RI           ≥ 4 units               473               37.5      4.7    27.0   3.7
  PROMMTT (secondary analysis)   \< 4 units               762                                       38.8           5.2          23.5                    3.3                                       
  Stone et al.[@B23]             USA                      Observational, single center              2012--2015     MT           With MT                 8                 59.1      20.5   31.1   15.8
  Without MT                     59                       38.8                                      17.0           8.2          3.0                                                               
  CAT                            With CAT                 21                                        46.8           19.6         20.1                    5.5                                       
  Without CAT                    46                       38.7                                      17.6           7.6          2.6                                                               
  Tran et al.[@B24]              Canada                   Observational, single center              2014--2017     MT           With MT                 48                40.5             33.8   6.8
  CAT                            With CAT                 145                                       53.0                        28.5                    3.3                                       

ISS = injury severity score, SD = standard deviation, MT = massive transfusion (≥ 10 pRBC/24 hours), CAT = critical administration threshold (≥3 pRBC/1 hour), RI = resuscitation intensity, MTP = massive transfusion protocol, pRBC = packed red blood cells, FFP = fresh frozen plasma, TQIP = the American College of Surgeons Trauma Quality Improvement Program, PROPPR = the Pragmatic, Randomized, Optimal Platelet and Plasma Ratios trial, RCT = randomized controlled trial, PROMMTT = Prospective, Observational, Multicenter, Major Trauma Transfusion study.

^a^The trauma registry of the German trauma society.

ISS and mortality of patients with MT
-------------------------------------

Before analyzing the mortality rate, the estimated ISS was investigated. The estimated ISS of patients with and without MT were 29.36 (95% confidence interval \[CI\], 29.25--29.47) and 21.72 (95% CI, 21.57--21.88), respectively. In patients with and without CAT, the estimated ISS were 28.20 (95% CI, 27.92--28.48) and 7.60 (95% CI, 6.84--8.36), respectively ([Table 2](#T2){ref-type="table"}). The estimated ISS of patients with RI ≥ 4U was 29.30 (95% CI, 28.95--29.65). At 24 hours, the estimated mortality rates were 0.194 (95% CI, 0.194--0.249), 0.126 (95% CI, 0.060--0.246), and 0.168 (95% CI, 0.129--0.216) in patients with MT, CAT, and RI, respectively ([Table 3](#T3){ref-type="table"}). Overall, the estimated mortality rates were 0.346 (95% CI, 0.258--0.446) and 0.223 (95% CI, 0.166--0.229) in patients with MT and CAT, respectively. The mortality rates were lower in patients without MT compared to patients with MT or CAT. To assess publication bias, Begg\'s funnel plot and Egger\'s test were preferentially conducted. In a mortality assessment of patients with MT at 24 hours and 30 days, there was significant publication bias (*P* = 0.028 and *P* = 0.007, respectively). To define the degree of publication bias, the fail-safe N and trim and fill tests were conducted as secondary assessments, and no significant publication bias was found. In assessing other subgroups, no significant publication bias emerged.

###### The estimated injury severity score in trauma patients: ISS
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  Variables   No. of subsets   Fixed effect (95% CI)   Heterogeneity test (*P* value)   Random effect (95% CI)   Egger\'s test (*P* value)   
  ----------- ---------------- ----------------------- -------------------------------- ------------------------ --------------------------- -------
  MT          19               29.36 (29.25--29.47)    \< 0.001                         31.87 (29.41--34.34)     0.545                       
              Without MT       6                       21.72 (21.57--21.88)             \< 0.001                 21.64 (17.58--25.70)        0.849
  CAT         3                28.20 (27.92--28.48)    \< 0.001                         26.40 (24.56--28.23)     0.317                       
              Without CAT      1                       7.60 (6.84--8.36)                1.000                    7.60 (6.84--8.36)           \-
  RI ≥ 4U     1                29.30 (28.95--29.65)    1.000                            29.30 (28.95--29.65)     \-                          

CI = confidence interval, ISS = injury severity score, MT = massive transfusion (≥ 10 pRBC/24 hours), CAT = critical administration threshold (≥3 pRBC/1 hour), RI = resuscitation intensity.

###### The estimated mortality rates in trauma patients
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  Variables   No. of subsets   Fixed effect (95% CI)   Heterogeneity test (*P* value)   Random effect (95% CI)   Egger\'s test (*P* value)                          
  ----------- ---------------- ----------------------- -------------------------------- ------------------------ --------------------------- ---------------------- -------
  At 24 hr                                                                                                                                                          
              MT               11                      0.236 (0.217--0.257)             \< 0.001                 0.194 (0.194--0.249)        0.028                  
                               Without MT              6                                0.077 (0.064--0.091)     \< 0.001                    0.060 (0.029--0.118)   0.511
              CAT              2                       0.158 (0.132--0.188)             0.009                    0.126 (0.060--0.246)        \-                     
                               Without CAT             2                                0.039 (0.022--0.067)     \< 0.001                    0.015 (0.001--0.270)   \-
              RI ≥ 4 units     2                       0.170 (0.147--0.196)             0.075                    0.168 (0.129--0.216)        \-                     
              RI \< 4 units    2                       0.097 (0.079--0.117)             0.001                    0.105 (0.052--0.201)        \-                     
  At 30 day                                                                                                                                                         
              MT               8                       0.386 (0.357--0.416)             \< 0.001                 0.325 (0.260--0.397)        0.007                  
                               Without MT              3                                0.131 (0.111--0.153)     \< 0.001                    0.079 (0.015--0.327)   0.650
              CAT              1                       0.062 (0.033--0.115)             1.000                    0.062 (0.033--0.115)        \-                     
                               Without CAT             1                                0.007 (0.003--0.016)     1.000                       0.007 (0.003--0.016)   \-
  Overall                                                                                                                                                           
              MT               16                      0.280 (0.272--0.289)             \< 0.001                 0.346 (0.258--0.446)        0.141                  
                               Without MT              5                                0.129 (0.109--0.152)     \< 0.001                    0.092 (0.041--0.191)   0.428
              CAT              2                       0.223 (0.166--0.293)             0.858                    0.223 (0.166--0.293)        \-                     
                               Without CAT             2                                0.047 (0.034--0.065)     0.420                       0.047 (0.034--0.065)   \-

CI = confidence interval, MT = massive transfusion (≥ 10 pRBC/24 hours), CAT = critical administration threshold (≥ 3 pRBC/1 hour), RI = resuscitation intensity.

Predicting roles of MT, CAT, and RI through a DTA review
--------------------------------------------------------

DTA review was performed to evaluate the predicting roles of MT, CAT, and RI in trauma patients ([Supplementary Table 1](#S1){ref-type="supplementary-material"}). At 6 hours, the pooled sensitivity and specificity of RI were 0.72 (95% CI, 0.64--0.78) and 0.55 (95% CI, 0.52--0.57), respectively ([Fig. 2](#F2){ref-type="fig"}). At 24 hours, the paired forest plot of the pooled sensitivity and specificity of MT, CAT, and RI are shown in [Fig. 3](#F3){ref-type="fig"}. The pooled sensitivity of CAT (0.89; 95% CI, 0.82--0.94) was significantly higher than MT (0.63; 95% CI, 0.57--0.68) and RI (0.69; 95% CI, 0.63--0.75). Overall, the paired forest plot of the pooled sensitivity and specificity of MT and CAT are shown in [Fig. 4](#F4){ref-type="fig"}. The pooled specificity of MT and CAT was 0.82 (95% CI, 0.80--0.83) and 0.85 (95% CI, 0.83--0.88), respectively, while the pooled sensitivity was 0.49 (95% CI, 0.44--0.54) and 0.50 (95% CI, 0.38--0.62), respectively. At 24 hours and overall, the AUC on SROC of MT were 0.6838 and 0.6557, respectively. At 24 hours, diagnostic ORs of MT, CAT, and RI were 3.75 (95% CI, 1.71--8.24), 9.25 (95% CI, 0.91--94.42), and 2.74 (95% CI, 2.05--3.67), respectively.

![Paired forest plot of the sensitivity and specificity of RI \> 4 unit for 6 hours mortality after admission.\
RI = resuscitation intensity, CI = confidence interval.](jkms-34-e318-g002){#F2}

![Paired forest plot of the sensitivity and specificity of (**A**, **B**) MT, (**C**, **D**) CAT, and (**E**, **F**) RI for 24 hours mortality after admission.\
MT = massive transfusion, CAT = critical administration threshold, RI = resuscitation intensity, CI = confidence interval.](jkms-34-e318-g003){#F3}

![Paired forest plot of the sensitivity and specificity of (**A**, **B**) MT and (**C**, **D**) CAT for overall mortality.\
MT = massive transfusion, CAT = critical administration threshold, CI = confidence interval.](jkms-34-e318-g004){#F4}

Quality assessment
------------------

The details of quality assessment are described in [Supplementary Table 2](#S2){ref-type="supplementary-material"}. The risk of bias was unclear in seven studies (41.1%) and the concern of applicability was unclear in three studies (17.6%). The majority of the included studies were retrospective observational studies.

DISCUSSION
==========

To the best of our knowledge, the present study is the first meta-analysis addressing the prognostic value of MT, CAT, and RI for mortality. In the present study, the DTA review suggested that CAT was the most sensitive surrogate for 24-hour mortality among the three assessments. RI appears as sensitive as MT for 24-hour mortality. Because CAT and RI are assessed within one hour, these are useful surrogates for 24-hour mortality, while MT is useless within 24 hours. Overall, the sensitivity of both MT and CAT were insufficient (0.49 and 0.50, respectively). However, specificity was 0.82 and 0.85, respectively. This high specificity compared to sensitivity implies that patients with MT have higher mortality rates than those without MT. The present study also revealed the estimated mortality rate and ISS for each assessment (MT, CAT, and RI). The pooled mortality rate and ISS were high in each positive assessment. This indicates that all assessments are associated with the severity of the patients\' condition.

In the era of DCR,[@B2] transfusion for severe traumatic hemorrhage is a major concern and a big challenge for trauma surgeons. Two recent major trials regarding DCR have suggested that the guidance of damage control is needed. One is multicenter prospective observational study conducted at 10 level 1 trauma centers in the United States.[@B26] The other is multicenter randomized control trial conducted at 12 level 1 trauma centers in the United States.[@B27] Both studies supported the benefits of high ratios of plasma and platelets. The primary variable in the design of these studies was the ratio of blood components, not the amount of blood. Three studies, using secondary analysis of both major studies, were included in the present study.[@B3][@B9][@B10]

The need for transfusion implies latent hemorrhage of internal organs, which is related to an adverse prognosis. Additionally, the transfusion itself can contribute to transfusion-related acute lung injury and various immunologic or non-immunologic adverse reactions.[@B28] Thus, the amount of transfused blood is possibly a major risk factor for predicting mortality. However, survival bias may influence results in the setting of the classic definition of MT because excluded patients who died early and the treatment for severe trauma patients are usually time-dependent variables.[@B5][@B29] Therefore, other assessments, such as CAT and RI, are warranted for predicting early mortality within 24 hours; however, as shown in our systematic review, evidence of these assessments is limited.

Tran et al.,[@B24]in their recent systematic review and meta-analysis including 84 studies, noted acceptable prediction models for mortality describing the mechanisms of injury, systolic blood pressure, heart rate, hemoglobin, lactate, international normalized ratio, and focused abdominal sonography for trauma. All pooled ORs for each variable were significant. However, the authors noted that a high-quality, evidence-based prediction model was lacking; MT, CAT, and RI were not eligible in their analysis. The prediction of traumatic mortality still needs more evidence.

Among eligible studies, only three had CAT outcomes. In a retrospective review of a single level 1 trauma center in Canada,[@B24] CAT+ demonstrated significantly higher sensitivity than MT+ for the composition of 24-hour hemorrhage-related mortality and the need for hemostatic intervention as determined by the AUC (0.815 vs. 0.644, *P* \> 0.001). Meyer et al.,[@B10] in the secondary analysis of the Pragmatic, Randomized, Optimal Platelet and Plasma Ratios trial (PROPPR) study,[@B27] demonstrated that both CAT and RI are valid surrogates for early mortality. In this study, CAT+ showed the best sensitivity and RI+ showed better specificity with good positive predictive value. Another study,[@B23] which had CAT outcomes, was a pilot study that had a small sample size.

Rahbar et al.[@B9] reported in their re-analysis of the PROMMTT study,[@B26] which was an observational clinical study conducted at 10 level 1 trauma centers in the United States, that RI in the first 30 minutes was significantly associated with 6- and 24-hour mortality. The study highlighted that the patients who received 4U or more of fluids were 2.2 fold more likely to die regardless of fluid type and 2.4 fold more likely to go to the operation room. The authors suggested that RI would be a more generalized definition for sickness and serve as surrogate for bleeding and mortality in severe trauma patients. Both CAT and RI appear potentially useful as surrogates for predicting early mortality in the trauma field. However, the distribution of both RI and CAT in published studies is limited based on our analysis.

The current analysis has several limitations. First, the number of extracted CAT and RI datasets was only two. Because of the small number of studies regarding CAT, the robustness of the statistical model was not secured, and more future studies will be needed. Although we acknowledge that an analysis including a small number of studies is not really the best option, paradoxically, we suggest that the present study takes the initiative in attempting to find a meaningful predictor for mortality. More sufficient studies regarding this issue are warranted. Second, the eligible studies for the present study included various heterogeneous datasets composed of single-center cohorts, multi-center cohorts, and a nationwide database. Although this heterogeneity, we could obtain a large number of patients\' data, especially due to national cohorts. Third, one of the eligible studies is an RCT and the others are non-RCT. Some other meta-analyses that were conducted distinguished RCTs from non-RCTs in their analyses. However, the key distinction should not be the design of the studies but an unbiased estimate of the effect size in question.[@B30] The key question of the present study was not focused on an intervention that determines a randomized allocation of patients; it focused instead on the prognosis of patients. Additionally, the original primary variable of the eligible RCT was the ratio of transfused blood components, and it was the secondary analysis of the original study. Thus, regardless of the study design, we computed the estimate of the summarized effect size. Fourth, we computed the estimated mortality rate and ISS used to combine single descriptive statistics.[@B30] Occasionally, a meta-analysis is used to assess the prevalence as shown in a previous study.[@B31] We aimed to investigate the mortality across the studies in terms of each assessment (MT, CAT, and RI).

Based on the present meta-analysis, CAT may be a more sensitive predictor for 24-hour mortality than other predictors. Furthermore, RI also appears to be a useful predictor for 24-hour mortality. Both MT and CAT showed high specificity for overall mortality. Despite limited evidence owing to the heterogeneous studies with small sample sizes, we suggest that these are the best available outcomes from the limited evidence at this point in time. Our analysis highlights the need for further large-scale prospective investigations regarding this issue. However, in hemodynamically unstable patients, such research designs will be a big challenge.
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